Shares of Celestica Inc. (TSE:CLS – Get Free Report) (NYSE:CLS) have been assigned an average recommendation of “Strong Buy” from the six research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a buy rating and five have given a strong buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is C$367.50.
CLS has been the subject of a number of recent research reports. TD Securities upgraded shares of Celestica from a “hold” rating to a “strong-buy” rating in a report on Wednesday, April 29th. TD upgraded Celestica from a “hold” rating to a “buy” rating and boosted their target price for the stock from C$350.00 to C$430.00 in a report on Wednesday, April 29th.
View Our Latest Analysis on CLS
Celestica Price Performance
Celestica (TSE:CLS – Get Free Report) (NYSE:CLS) last posted its quarterly earnings results on Monday, July 27th. The company reported C$3.61 earnings per share for the quarter. The firm had revenue of C$6.68 billion for the quarter. Celestica had a net margin of 7.15% and a return on equity of 50.28%. On average, equities analysts anticipate that Celestica will post 5.028804 EPS for the current fiscal year.
Celestica Company Profile
Celestica Inc offers supply chain solutions. The firm operates in two segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). ATS segment consists of the ATS end market and is comprised of A&D, Industrial, Energy, HealthTech, and Capital Equipment businesses. Capital Equipment business is comprised of our semiconductor, display, and power & signal distribution equipment businesses. CCS segment that derives majority revenue consists of Communications and Enterprise end markets.
Featured Stories
- Five stocks we like better than Celestica
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
